Partnership to bring accurate and fast genome analysis to translational researchers CAMBRIDGE, MA – May 6, 2013 – Knome Inc., the genome interpretation company, and Real Time Genomics, Inc., the genome analytics company, today announced that the Real Time Genomics (RTG) Variant platform will be integrated into every shipment of the knoSYS™100 interpretation … more
For those who missed us, allow us to fill you in on the excitement… A contingent of Knomies went out to San Francisco from November 6-10 for the annual meeting of the American Society of Human Genetics. There we had the pleasure of engaging with a number of geneticists, genomicists, … more
An excerpt of an interesting article featuring Knome… The price of sequencing a person’s genome — putting in order all three billion base pairs of DNA in a set of human chromosomes — keeps dropping. But interpreting the billions of letters in a person’s DNA blueprint for use in medicine, … more
An excerpt of an interesting article mentioning Knome [emphasis ours]… Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome camp and only came home with a lousy … more
An excerpt of an interesting article mentioning Knome [emphasis ours]: …Cambridge, Massachusetts–based Knome made one of the splashiest entries into the field, but has now turned entirely to contract research. The company began providing DTC whole-genome sequencing to independently wealthy individuals at a time when the price was still sky … more
Watch our co-founder George Church on The Colbert Report promoting his book Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves.
First Plug-and-Play Human Genome Interpretation System – Big data technology breaks the genome interpretation bottleneck – An in silico genetic testing “lab in a box” – More than a dozen leading institutions join early access program CAMBRIDGE, MA – September 27, 2012 – Knome Inc. announced today that it … more
Dr. Rehm brings deep experience in clinical genomics and patient care as Knome continues to expand CAMBRIDGE, MA – July 9, 2012 – Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, Heidi Rehm, PhD, has joined the company’s scientific advisory board. “Dr. Rehm is … more